Article Information
History
- June 4, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Antonio G. Dias Jr.1,†,‡,
- Elias Duarte1,†,
- Jose Victor Zambrana2,
- Jaime A. Cardona-Ospina1,
- Sandra Bos1,
- Vicky Roy3,
- Guillermina Kuan4,5,
- Angel Balmaseda4,6,
- Galit Alter3,§ and
- Eva Harris1,*
- 1Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA
- 2Department of Epidemiology, School of Public Health, University of Michigan, Ann Harbor, MI, USA
- 3Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
- 4Sustainable Sciences Institute, Managua, Nicaragua
- 5Centro de Salud Sócrates Flores Vivas, Ministerio de Salud, Managua, Nicaragua
- 6Laboratorio Nacional de Virologia, Centro Nacional de Diagnóstico y Referencia, Ministerio de Salud, Managua, Nicaragua
- ↵* Corresponding author; email: eharris{at}berkeley.edu
↵† These authors contributed equally to this work.
Posted June 04, 2024.
Complement-dependent virion lysis mediated by dengue-Zika virus cross-reactive antibodies correlates with protection from severe dengue disease
